5,10-methylenetetrahydrofolic acid: Clinical Trials

4 trials of 5,10-methylenetetrahydrofolic acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 24Completed 4

Follow 5,10-methylenetetrahydrofolic acid: new trials by email Literature Review of 5,10-methylenetetrahydrofolic acid trials Research Report on 5,10-methylenetetrahydrofolic acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
Modufolin (arfolitixorin), Fluorouracil, Oxaliplatin - Colorectal Neoplasm
Phase 1 / Phase 2CompletedIsofol Medical AB1052014-09-012020-09-09
Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
Calcium Folinate, [6R] 5,10-methylenetetrahydrofolate (arfolitixorin) - Osteosarcoma
Phase 1 / Phase 2CompletedIsofol Medical AB182013-12-012020-09-25
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
6R-MTHF (arfolitixorin) 200 mg/m2, Levoleucovorin 200 mg/m2, 6R-MTHF (arfolitixorin) 60 mg/m2 - Colonic Neoplasms
Phase 1 / Phase 2CompletedIsofol Medical AB322012-09-012020-09-25
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
[6R] 5,10-methylenetetrahydrofolate (arfolitixorin), Pemetrexed - Rectal Cancer
Phase 1 / Phase 2CompletedIsofol Medical AB242011-04-142020-09-09

Conditions studied

Colorectal Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Neoplasms (3)  ·  Digestive System Neoplasms (2)  ·  Rectal Neoplasms (2)  ·  Colonic Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Intestinal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Osteosarcoma (1)  ·  Rectal Diseases (1)

Sponsors

Isofol Medical AB (4)

Countries

Sweden (4)  ·  Czechia (1)  ·  Denmark (1)  ·  Greece (1)  ·  Hungary (1)  ·  Norway (1)  ·  Poland (1)

Top investigators

Bengt G Gustavsson, PhD, MD (1)  ·  Kristoffer Derwinger, MD PhD (1)  ·  Mikael Eriksson, MD PhD (1)

Results publications

PMID 33099678, PMID 36183444

NIH funding

2014 (1)